Biochemical engineering of the N-acyl side chain of sialic acid: biological implications.

N-Acetylneuraminic acid is the most prominent sialic acid in eukaryotes. The structural diversity of sialic acid is exploited by viruses, bacteria, and toxins and by the sialoglycoproteins and sialoglycolipids involved in cell-cell recognition in their highly specific recognition and binding to cellular receptors. The physiological precursor of all sialic acids is N-acetyl D-mannosamine (ManNAc). By recent findings it could be shown that synthetic N-acyl-modified D-mannosamines can be taken up by cells and efficiently metabolized to the respective N-acyl-modified neuraminic acids in vitro and in vivo. Successfully employed D-mannosamines with modified N-acyl side chains include N-propanoyl- (ManNProp), N-butanoyl- (ManNBut)-, N-pentanoyl- (ManNPent), N-hexanoyl- (ManNHex), N-crotonoyl- (ManNCrot), N-levulinoyl- (ManNLev), N-glycolyl- (ManNGc), and N-azidoacetyl D-mannosamine (ManNAc-azido). All of these compounds are metabolized by the promiscuous sialic acid biosynthetic pathway and are incorporated into cell surface sialoglycoconjugates replacing in a cell type-specific manner 10-85% of normal sialic acids. Application of these compounds to different biological systems has revealed important and unexpected functions of the N-acyl side chain of sialic acids, including its crucial role for the interaction of different viruses with their sialylated host cell receptors. Also, treatment with ManNProp, which contains only one additional methylene group compared to the physiological precursor ManNAc, induced proliferation of astrocytes, microglia, and peripheral T-lymphocytes. Unique, chemically reactive ketone and azido groups can be introduced biosynthetically into cell surface sialoglycans using N-acyl-modified sialic acid precursors, a process offering a variety of applications including the generation of artificial cellular receptors for viral gene delivery. This group of novel sialic acid precursors enabled studies on sialic acid modifications on the surface of living cells and has improved our understanding of carbohydrate receptors in their native environment. The biochemical engineering of the side chain of sialic acid offers new tools to study its biological relevance and to exploit it as a tag for therapeutic and diagnostic applications.

[1]  M. Pawlita,et al.  Biosynthesis of N-Acetylneuraminic Acid in Cells Lacking UDP-N-Acetylglucosamine 2-Epimerase/ N-Acetylmannosamine Kinase , 2001, Biological chemistry.

[2]  S. Sad,et al.  Biochemical Engineering of Surface α2–8 Polysialic Acid for Immunotargeting Tumor Cells* , 2000, The Journal of Biological Chemistry.

[3]  D. Koshland,et al.  Biosynthetic incorporation of unnatural sialic acids into polysialic acid on neural cells. , 2000, Glycobiology.

[4]  H. Kettenmann,et al.  Incorporation of N‐propanoylneuraminic acid leads to calcium oscillations in oligodendrocytes upon the application of GABA , 2000, FEBS letters.

[5]  C. Bertozzi,et al.  Cell surface engineering by a modified Staudinger reaction. , 2000, Science.

[6]  R. Schnaar,et al.  Conversion of cellular sialic acid expression from N-acetyl- to N-glycolylneuraminic acid using a synthetic precursor, N-glycolylmannosamine pentaacetate: inhibition of myelin-associated glycoprotein binding to neural cells. , 2000, Glycobiology.

[7]  W. Reutter,et al.  Selective Loss of either the Epimerase or Kinase Activity of UDP-N-acetylglucosamine 2-Epimerase/N-Acetylmannosamine Kinase due to Site-directed Mutagenesis Based on Sequence Alignments* , 1999, The Journal of Biological Chemistry.

[8]  W. Reutter,et al.  In vivo modulation of the acidic N-glycans from rat liver dipeptidyl peptidase IV by N-propanoyl-D-mannosamine. , 1999, Biochemical and biophysical research communications.

[9]  C. Bertozzi,et al.  Engineering Novel Cell Surface Receptors for Virus-mediated Gene Transfer* , 1999, The Journal of Biological Chemistry.

[10]  A. Monto,et al.  Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial. , 1999, JAMA.

[11]  M. Peter,et al.  Differential sialylation of cell surface glycoconjugates in a human B lymphoma cell line regulates susceptibility for CD95 (APO-1/Fas)-mediated apoptosis and for infection by a lymphotropic virus. , 1999, Glycobiology.

[12]  M. Pawlita,et al.  UDP-GlcNAc 2-epimerase: a regulator of cell surface sialylation. , 1999, Science.

[13]  M. Pawlita,et al.  Elongation of theN-Acyl Side Chain of Sialic Acids in MDCK II Cells Inhibits Influenza A Virus Infection , 1998 .

[14]  C. Bertozzi,et al.  Metabolic Delivery of Ketone Groups to Sialic Acid Residues , 1998, The Journal of Biological Chemistry.

[15]  W. Reutter,et al.  Biochemical Engineering of Neural Cell Surfaces by the SyntheticN-Propanoyl-substituted Neuraminic Acid Precursor* , 1998, The Journal of Biological Chemistry.

[16]  M. Pawlita,et al.  Elongation of the N-acyl side chain of sialic acids in MDCK II cells inhibits influenza A virus infection. , 1998, Biochemical and biophysical research communications.

[17]  J. Esko,et al.  Fucosylation of Disaccharide Precursors of Sialyl LewisX Inhibit Selectin-mediated Cell Adhesion* , 1997, The Journal of Biological Chemistry.

[18]  W. Reutter,et al.  A Bifunctional Enzyme Catalyzes the First Two Steps in N-Acetylneuraminic Acid Biosynthesis of Rat Liver , 1997, The Journal of Biological Chemistry.

[19]  M. Pawlita,et al.  Consequences of a subtle sialic acid modification on the murine polyomavirus receptor , 1997, Journal of virology.

[20]  H. Jennings,et al.  N-Propionylated Group B Meningococcal Polysaccharide Mimics a Unique Bactericidal Capsular Epitope in Group B Neisseria meningitidis , 1997, The Journal of experimental medicine.

[21]  C. Bertozzi,et al.  Engineering chemical reactivity on cell surfaces through oligosaccharide biosynthesis. , 1997, Science.

[22]  F. Oesch,et al.  In vivo modulated N‐acyl side chain of N‐acetylneuraminic acid modulates the cell contact‐dependent inhibition of growth , 1996, FEBS letters.

[23]  H. Gross,et al.  Ecto-sialyltransferase of human B lymphocytes reconstitutes differentiation markers in the presence of exogenous CMP-N-acetyl neuraminic acid. , 1996, Blood.

[24]  M. Fukuda Possible roles of tumor-associated carbohydrate antigens. , 1996, Cancer research.

[25]  S. Harrison,et al.  Crystal structures of murine polyomavirus in complex with straight-chain and branched-chain sialyloligosaccharide receptor fragments. , 1996, Structure.

[26]  T. A. Fritz,et al.  Disaccharide uptake and priming in animal cells: inhibition of sialyl Lewis X by acetylated Gal beta 1-->4GlcNAc beta-O-naphthalenemethanol. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Pawlita,et al.  Biosynthetic Modulation of Sialic Acid-dependent Virus-Receptor Interactions of Two Primate Polyoma Viruses (*) , 1995, The Journal of Biological Chemistry.

[28]  S. Kelm,et al.  Biochemistry and Role of Sialic Acids , 1995 .

[29]  S. Watowich,et al.  Crystal structures of influenza virus hemagglutinin in complex with high-affinity receptor analogs. , 1994, Structure.

[30]  Thilo Stehle,et al.  Structure of murine polyomavirus complexed with an oligosaccharide receptor fragment , 1994, Nature.

[31]  N. van Zandwijk,et al.  NCAM and lung cancer , 1994, International journal of cancer. Supplement = Journal international du cancer. Supplement.

[32]  P. Lackie,et al.  In vitro and in vivo growth of clonal sublines of human small cell lung carcinoma is modulated by polysialic acid of the neural cell adhesion molecule. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[33]  D. M. Ryan,et al.  Rational design of potent sialidase-based inhibitors of influenza virus replication , 1993, Nature.

[34]  A. Varki,et al.  Biological roles of oligosaccharides: all of the theories are correct , 1993, Glycobiology.

[35]  W. Reutter,et al.  Biosynthesis of a nonphysiological sialic acid in different rat organs, using N-propanoyl-D-hexosamines as precursors. , 1992, The Journal of biological chemistry.

[36]  W. Reutter,et al.  Incorporation of N‐acyl‐2‐amino‐2‐deoxy‐hexoses into glycosphingolipids of the pheochromocytoma cell line PC 12 , 1992, FEBS letters.

[37]  F. A. Troy,et al.  Polysialylation: from bacteria to brains. , 1992, Glycobiology.

[38]  W. Reutter,et al.  Kayser, H. et al. Biosynthesis of a nonphysiological sialic-acid in different rat organs, using N-propanoyl-D-hexosamines as precursors. J. Biol. Chem. 267, 16934-16938 , 1992 .

[39]  S. Teneberg,et al.  Receptor‐active glycolipids of epithelial cells of the small intestine of young and adult pigs in relation to susceptibility to infection with Escherichia coli K99 , 1990, FEBS letters.

[40]  A. Kobata,et al.  Function and pathology of the sugar chains of human immunoglobulin G. , 1989, Ciba Foundation symposium.

[41]  S. Cusack,et al.  Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid , 1988, Nature.

[42]  J. Paulson,et al.  Sialyloligosaccharide receptors of binding variants of polyoma virus. , 1983, Virology.

[43]  M. Greaves,et al.  Receptors and Recognition , 1976, Series A.